Forward Pharma IPO Research Information

Forward Pharma IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Forward Pharma, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Forward Pharma	FWP - NASDAQ	$20.00-$22.00	$21.00	$18.99	10.5 million	10/15/2014
Underwriter(s): Leerink Partners, Jefferies, RBC Capital Markets
Co-Manager(s): JMP Securities
Industry: Health Care
Filing(s): Filed 2014-08-11 Terms Added 2014-10-02

Forward Pharma Quote & Chart - Click for current quote - FWP

About Forward Pharma (adapted from Forward Pharma prospectus):
Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a Phase 3 clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients.

This description is adapted from Forward Pharma prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Forward Pharma "FWP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.